Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization 2021-01-13 03:13
Organizations Collaborate to Develop International State-of-the-Art Guidelines on the Diagnosis and Management of von Willebrand Disease 2021-01-13 03:06
Guide Sensmart Launches New Guide QT Series IR Fever Warning System for Temperature Measurement featuring 5-minute Easy Installation 2021-01-13 01:47
BitePRO Report Record Sales Of Bite Resistant Clothing Due To Increasing Violence In Schools 2021-01-12 23:11
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer 2021-01-12 23:00
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-12 22:57
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories 2021-01-12 21:20
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer 2021-01-12 13:02
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
Regent Pacific Announces Key Research Findings On FORTACIN™ 2021-01-11 23:36
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services 2021-01-11 19:05
Airnov Made Its Debut at CPhI China 2021-01-11 16:26
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA. 2021-01-11 11:33
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-11 07:26
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership 2021-01-11 07:00
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients 2021-01-10 16:55
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 2021-01-08 20:55
1 315 316 317 318 319 531